Stock screenerAll disclosures →
EDGAR →
EXEL
Conviction 100HealthcareScan · Thu, Jun 25, 2026EXEL$53.22+0.66%
ResistanceSupportVol 14Insider sell2
2
3
Vol MA14 2.92M
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price53.22
Change+0.66%
Gap-0.32%
Rel volume2.70×
Avg volume2.91M
Avg $ vol151.36M
SMA 2051.99
SMA 5049.09
SMA 20043.78
Price vs 50+8.41%
Price vs 200+21.56%
MA stackbullish
50/200 cross—
Supertrendup · 48.98
RSI (14)60
MACD hist-0.17
MACD crossbear · 6d
Stoch %K / %D77 / 66
ADX (14)25
+DI / −DI21 / 14
RSI divergenceBearish
MACD divergence—
ATR %+2.97%
ADR %3.12%
52w high53.50
52w low34.54
From 52w high-0.52%
Above 52w low+54.08%
New 52w highNo
SqueezeOff
Bollinger width9.05%
%B0.76
Donchian pos87.81%
Donchian high53.93
Donchian low48.10
AVWAP (52w high)52.42
vs AVWAP high+1.53%
AVWAP (52w low)44.23
vs AVWAP low+20.33%
OBV trendFlat
Chaikin MF (20)-0.03
Today vs 20d2.70×
Avg vol (14d)2.92M
Avg vol (20d)2.91M
Avg $ vol (20d)151.36M
Market cap13.38B
RS 3m (vs SPY)+14.93%
RS 6m (vs SPY)+11.61%
RS line new highNo
Trend template8/8
Technical rank81.3
1 week+1.49%
1 month+6.48%
3 months+24.39%
6 months+15.22%
1 year+16.40%
YTD+22.12%
P/E17.09
P/B6.91
P/S5.77
P/FCF15.27
EPS2.78
Div yield—
ROE40.43%
ROA30.17%
Debt/Eq0.10
Current3.26
EV/EBITDA14.80
Gross margin8.25%
Net margin33.73%
Rev growth6.98%
EPS growth50.13%
Price target48.10
Target upside-9.62%
Analyst ratingHold
Institutional114.81%
Ent. value13.34B
Revenue610.81M
Net income210.47M
Gross profit—
Free cash flow875.84M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out251.36M
Employees1.08K
ListedTue, Apr 11, 2000
Free float251.4M
Float %96.8%
Short interest29.71M
Days to cover12.3d
Short volume62.7%
Squeeze score79 / 100
Next earningsMon, Jul 27, 2026 (32d)
EPS forecast$0.75 · 4 est
Last EPS vs est$0.79 vs $0.67
Last surprise+17.9% beat
Setup gradeA+
Conviction100 / 100
Pattern quality—
Tech rank81.3 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance53.45
Support43.50
Days since event—
Candle confirm—
News sentiment—
Financials as of Fri, Apr 3, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in EXEL
No recent disclosed trades by Congress in EXEL. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in EXEL · 8 buys · 2 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
WYSZOMIERSKI JACK L Director · Common Stock · 2026-06-01 | Sell | 3.92K | $198K | 2026-06-01 | 2026-06-03 |
Eckhardt Sue Gail Director · Common Stock · 2026-06-01 | Sell | 9.81K | $492K | 2026-06-01 | 2026-06-03 |
Smith Julie Director · Common Stock · 2026-05-27 | Grant | 8.37K | $0 | 2026-05-27 | 2026-05-29 |
PAPADOPOULOS STELIOS Director · Common Stock · 2026-05-27 | Grant | 8.37K | $0 | 2026-05-27 | 2026-05-29 |
POSTE GEORGE Director · Common Stock · 2026-05-27 | Grant | 8.37K | $0 | 2026-05-27 | 2026-05-29 |
JOHNSON DAVID EDWARD Director · Option (right to buy) · 2026-05-27 | Grant | 19.13K | $0 | 2026-05-27 | 2026-05-29 |
Eckhardt Sue Gail Director · Common Stock · 2026-05-27 | Grant | 8.37K | $0 | 2026-05-27 | 2026-05-29 |
Freire Maria C Director · Common Stock · 2026-05-27 | Grant | 8.37K | $0 | 2026-05-27 | 2026-05-29 |
Oliver Bob Director · Common Stock · 2026-05-27 | Grant | 8.37K | $0 | 2026-05-27 | 2026-05-29 |
Heyman Tomas J. Director · Common Stock · 2026-05-27 | Grant | 8.37K | $0 | 2026-05-27 | 2026-05-29 |
SEC filings
EDGAR filings in EXEL · 2 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.